VOLUME 62   2001   NUMBER 8

CME Pretest 588

CME Posttest 663

Commentary

589 Grow the Market. Alan J. Gelenberg
[PDF]

Brainstorms

590 Gut Feelings About Irritable Bowel Syndrome. Stephen M. Stahl
[PDF]

Original Articles

592 Venlafaxine in the Treatment of Postpartum Depression. Lee S. Cohen, Adele C. Viguera, Suzanne M. Bouffard, Ruta M. Nonacs, Cassandra Morabito, Mary H. Collins, and J. Stuart Ablon
[Abstract] [PDF]

597 A Double-Blind Randomized Comparison of Nortriptyline Plus Perphenazine Versus Nortriptyline Plus Placebo in the Treatment of Psychotic Depression in Late Life. Benoit H. Mulsant, Robert A. Sweet, Jules Rosen, Bruce G. Pollock, George S. Zubenko, Tracy Flynn, Amy E. Begley, Sati Mazumdar, and Charles F. Reynolds III
[Abstract] [PDF]

605 Risperidone Added to Clozapine: Impact on Serum Prolactin Levels. David C. Henderson, Donald C. Goff, Christine E. Connolly, Christina P. Borba, and Doug Hayden
[Abstract] [PDF]

609 Why Do Young Women Diet? The Roles of Body Fat, Body Perception, and Body Ideal. [CME] Amanda J. Gruber, Harrison G. Pope, Jr., Justine K. Lalonde, and James I. Hudson
[Abstract] [PDF]

612 The Impact of Antidepressant Discontinuation Versus Antidepressant Continuation on 1-Year Risk for Relapse of Bipolar Depression: A Retrospective Chart Review. Lori Altshuler, Lindsay Kiriakos, Jeff Calcagno, Robyn Goodman, Michael Gitlin, Mark Frye, and Jim Mintz
[Abstract] [PDF]

617 Virtual Reality Exposure Therapy for Vietnam Veterans With Posttraumatic Stress Disorder. Barbara O. Rothbaum, Larry F. Hodges, David Ready, Ken Graap, and Renato D. Alarcon
[Abstract] [PDF]

623 Efficacy and Safety of Risperidone in the Treatment of Schizoaffective Disorder: Initial Results From a Large, Multicenter Surveillance Study. Eduard Vieta, Marisa Herraiz, Antonio Fernandez, Cristobal Gasto, Antonio Benabarre, Francesc Colom, Anabel Martinez-Aran, Maria Reinares for the Group for the Study of Risperidone in Affective Disorders (GSRAD)
[Abstract] [PDF]

631 A 1-Year Follow-Up Study of Behavioral and Psychological Symptoms in Dementia Among People in Care Environments. [CME] Clive G. Ballard, Marisa Margallo-Lana, Jane Fossey, Katharina Reichelt, Pat Myint, Dawn Potkins, and John O'Brien
[Abstract] [PDF]

637 Patterns of Temperament and Character in Subjects With Obsessive-Compulsive Disorder. In Kyoon Lyoo, Dong Woo Lee, Yeon Su Kim, Seog Weon Kong, and Jun Soo Kwon
[Abstract] [PDF]

642 Effects of Fluvoxamine and Paroxetine on Sleep Structure in Normal Subjects: A Home-Based Nightcap Evaluation During Drug Administration and Withdrawal. Rosalia Silvestri, Edward F. Pace-Schott, Tamara Gersh, Robert Stickgold, Carl Salzman, and J. Allan Hobson
[Abstract] [PDF]

Letters To the Editor

653 Auditory Hallucinations Associated With Topiramate. Scott C. Matthews and Brian P. Miller
[PDF]

653 Metformin in Obesity Associated With Antipsychotic Drug Administration: A Pilot Study. Trino Baptista, Luis Hernandez, Lisette Alvarez Prieto, Evelyn Cubillan Boyero, and Soaira de Mendoza
[PDF]

655 Reboxetine-Induced Hypomania. Eduard Vieta, Francesc Colom, Anabel Martinez-Aran, Maria Reinares, Antonio Benabarre, Barbara Corbella, and Cristobal Gasto
[PDF]

656 Tiagabine Improves Panic and Agoraphobia in Panic Disorder Patients. Peter Zwanzger, Thomas C. Baghai, Cornelius Schule, Christo Minov, Frank Padberg, Hans-Jurgen Moller, and Rainer Rupprecht
[PDF]

657 Switching From Benzodiazepines to Buspirone Using a Tapered Overlap Method in Generalized Anxiety Disorder. Mihaly Arato
[PDF]

658 Corrections. Doghramji PP. Detection of insomnia in primary care (J Clin Psychiatry 2001;62[suppl 10]:1826); Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial (J Clin Psychiatry 2001;62:350357)
[PDF]

Book Reviews 659

NOW@Psychiatrist.com 665

Information for Authors

see July 2001, pages 579-581 or our Web site at www.psychiatrist.com/author.htm